Esperion Therapeutics ESPR Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's work in process?
- Esperion Therapeutics (ESPR) reported work in process of $309K in Q1 2026.
- How has Esperion Therapeutics's work in process changed year-over-year?
- Esperion Therapeutics's work in process decreased by 85.1% year-over-year, from $2.07M to $309K.
- What is the long-term trend for Esperion Therapeutics's work in process?
- Over 5 years (2020 to 2025), Esperion Therapeutics's work in process has grown at a 17.5% compound annual growth rate (CAGR), from $2.03M to $4.53M.
- What does work in process mean?
- Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.